More than 8 million people in the U.S. take blood thinners, also called anticoagulants. Many are prescribed the drugs after ...
A detective investigating a murder stumbled on something else — a “case within a case,” he called it — involving a long-lost ...
CREATINE has spent decades hiding in the gym, enhancing the workouts of bodybuilders and athletes. But the supplement is now ...
Nine-year follow-up of gene therapy in haemophilia B confirms long-term safety and reduced bleeding, though full capsid ...
Kite, a Gilead Company , today announced the U.S. Food and Drug Administration (FDA) approved an update to the Yescarta® (axicabtagene ciloleucel) prescribing information removing the previous ...
According to Statista's 2025 ranking, the 20 best-selling medicines in the world generated revenues of more than $250 billion ...
News-Medical.Net on MSN
Investigational anti-clotting drug reduces risk of second ischemic stroke without bleeding concerns
An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic ...
SAN DIEGO -- Type 2 diabetes patients may have a lower risk of venous thromboembolism (VTE) when treated with a GLP-1 receptor agonist, regardless of their obesity status, a database study involving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results